Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

357 Tue, 8/1/2017, 10:30 AM - 11:15 AM CC-Halls A&B
SPEED: Biopharmaceutical Statistics — Contributed Poster Presentations
Biopharmaceutical Section , Section on Statistical Learning and Data Science
Chair(s): Jessi Cisewski, Yale University
The Speed portion will take place during Session 214526
1: Tradeoffs of a Randomize, Then Consent Approach to Improving Cluster Participation Rates in Cluster Randomize Trials Abigail Shoben, The Ohio State University
2: Sample Size for Joint Testing Cause-Specific Hazard and Overall Hazard in the Presence of Competing Risks Qing Yang, Duke University ; Gang Li, University of California, Los Angeles
3: Accounting for Baseline Covariates and Missing Data in Regulatory Trials with Longitudinal Designs Elizabeth Colantuoni, Johns Hopkins University ; Jon Steingrimsson, Johns Hopkins University ; Aidan McDermott, Johns Hopkins University ; Michael Rosenblum, Johns Hopkins University
4: Robust Feature Selection and Cell Line Classification with Electric Cell-Substrate Impedance Sensing Data Megan Gelsinger, Cornell University ; David S Matteson, Cornell University ; Laurie Tupper, Williams College
5: Comparing Biomarker-Guided Treatment Strategies Using Local Posterior Predictive Benefit Meilin Huang, The University of Texas MD Anderson Cancer Center ; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
6: A Comparison of Assay Platforms Using Correlation Coefficients in the Presence of Repeated Measurements Qinlei Huang, Merck & Co. ; Radha Railkar, Merck & Co. ; Anita Lee, Merck & Co.
8: On Measure of Surrogacy for Biomarkers in Medical Research. Rui Zhuang, University of Washington ; Ying Qing Chen, Fred Hutchinson Cancer Research Center
9: Discriminant Analysis (DA) Based Methods in Safety Evaluation Angang Zhang, Merck ; Richard Baumgartner, Merck ; William W Wang, Merck & Co Inc
10: On the Estimation of Risk Difference in the Presence of Continuous Baseline Covariates Hua Ma, Merck ; Robin Mogg, Merck
11: Power Comparison of Tests of Restricted Mean Survival Time with Log-Rank Test and Generalized Wilcoxon Test Under Various Survival Distributions Musashi Fukuda, Astellas Pharma Inc. ; Yutaka Matsuyama, Department of Biostatistics, School of Public Health, The University of Tokyo
12: Optimal Designs for Pharmacokinetic Studies Analyzed Using Non-Compartmental Methods Helen Barnett, Lancaster University ; Thomas Jaki, Lancaster University ; Helena Geys, Janssen Pharmaceutica ; Tom Jacobs, Janssen Pharmaceutica
13: Statistical Considerations in Delayed-Start Design to Demonstrate Disease Modification Effect in Neurodegenerative Disorders Jun Zhao, AbbVie Inc. ; Deli Wang, AbbVie, Inc. ; Weining Z Robieson, AbbVie Inc.
14: Placebo-Based Multiple Imputation Methods for Sensitivity Analysis in Recurrent Event Data Rui Yang, Chiltern International Inc
15: Sample Size Calculation for the Generalized Poisson Regression Model Comparing Two Rates of Recurrent Events Kimitoshi Ikeda, Amgen Astellas BioPharma K.K.
16: Sample Size Calculation to Support Local Submission Zhuqing Yu, AbbVie ; Bidan Huang, AbbVie ; Jun Zhao, AbbVie Inc. ; lu cui, Abbvie
17: An Examination of the Association Between Alcohol and Dementia in a Longitudinal Study Tingting Hu, Florida State University ; Dan McGee, Florida State University ; Elizabeth Slate, Florida State University
18: Design and Statistical Analysis of Method Transfer Studies for Biotechnology Products Meiyu Shen, C DER, FDA ; Lixin Xu, FDA
Copyright © American Statistical Association